Skip to content
OpenCapital
Get started

Synopsys SNPS Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
EDA66.9%—
Design IP30%—
Ansys0%—

Other financials

Income statement

See full
Revenue$2.3B+41.9%
Gross profit$1.6B+28.0%
Operating income$120.4M-68.0%
Net income$17.1M-95.0%
EPS (diluted)$0.09-95.9%

Balance sheet

See full
Cash & equivalents$198.1M-98.6%
Total debt$10.8B+0.9%
Total equity$30.5B+207%
Total assets$46.9B+97.4%

Cash flow

See full
Operating cash flow$628.9M+128%
CapEx$54.2M-2.5%
Free cash flow$574.7M+162%

Valuation

See full
Market cap$87.13B+19.3%
Enterprise value$97.77B+40.4%
P/E112.7×+78.9×
P/S10×-1.7×

Profitability

See full
Gross margin73.5%-6.4pp
Operating margin7%-13.9pp
Net margin8.9%-25.9pp
FCF margin30.3%+13.2pp

Returns & leverage

See full
Return on equity3.8%-21.5pp
Debt / equity0.4×-0.7×
Current ratio1.4×-5.6×